BioMed Central is a United Kingdom-based, for-profit scientific open access publisher that produces over 250 scientific journals. It is the first and largest open access science publisher.

BioMed Central

BMC Practise

Open Access Membership Program

BMC is a pioneer of open access publishing. We’re committed to innovation in research publishing to support the needs of our communities and ensure the integrity of the research we publish.

Our leading research journals include selective broad interest titles such as Genome Biology and Genome Medicine, academic journals such as Malaria Journal and Microbiome and the BMC series, 65 inclusive journals focused on the needs of individual research communities. We also partner with leading institutions and societies to publish journals on their behalf. 

BMC also manages the UK primary clinical trial registry ISRCTN (https://www.isrctn.com).

An article published in the Journal of Cheminformatics presents DeepSA: a deep-learning model for synthetic accessibility assessment of organic compounds, which provides a useful tool to choose molecules.


An article in the International Journal of Health Geographics presents GMOD: a free, public platform to improve the detection of invasive and vector mosquitoes by collecting and displaying mosquito observation and habitat data generated worldwide.



An On Medicine blog post discusses the ‘Teacher LGBT Inclusion study’ that is testing the effectiveness of an intervention to improve Romanian teachers’ outcomes related to LGBT+ inclusion.


An article published in Genome Medicine presents DeepGAMI: an interpretable neural network model to improve genotype–phenotype prediction from multimodal data.

Microbial communities growing on plastic debris in rivers may have the capacity to harbour potentially pathogenic microbes and act as reservoirs of antimicrobial resistance genes, according to a study published in Microbiome.

COM:BIOMEDCENTRAL

BioMed Central

Financials Not Available